{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=36600","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=36000","results":[{"registry_id":"NCT05267613","publication_url":"https://clinicaltrials.gov/study/NCT05267613","title":"A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05902533","publication_url":"https://clinicaltrials.gov/study/NCT05902533","title":"REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation","has_exemption":false,"start_date":"2023-08-14","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06748157","publication_url":"https://clinicaltrials.gov/study/NCT06748157","title":"Non-Invasive Median Nerve Stimulation to Attenuate Atrial Tachyarrhythmias After Catheter Ablation for Atrial Fibrillation","has_exemption":false,"start_date":"2024-10-02","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209475","publication_url":"https://clinicaltrials.gov/study/NCT07209475","title":"A Randomized Controlled Multicenter Trial, Examining the Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.","has_exemption":false,"start_date":"2025-08-14","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"Royal Biologics","sponsor_slug":"royal-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02940301","publication_url":"https://clinicaltrials.gov/study/NCT02940301","title":"A Phase 2 Trial of Ibrutinib and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma","has_exemption":false,"start_date":"2016-12-20","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03665831","publication_url":"https://clinicaltrials.gov/study/NCT03665831","title":"Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)","has_exemption":false,"start_date":"2018-10-23","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Rotman Research Institute at Baycrest","sponsor_slug":"rotman-research-institute-at-baycrest","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03974113","publication_url":"https://clinicaltrials.gov/study/NCT03974113","title":"ATLAS-PEDS: An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B","has_exemption":false,"start_date":"2020-01-28","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04585750","publication_url":"https://clinicaltrials.gov/study/NCT04585750","title":"A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients With Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)","has_exemption":false,"start_date":"2020-10-29","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"PMV Pharmaceuticals, Inc","sponsor_slug":"pmv-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04491370","publication_url":"https://clinicaltrials.gov/study/NCT04491370","title":"Safety and Tolerability of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Polatuzumab Vedotin (PV) Immunoconjugate Therapy in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-08-01","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444465","publication_url":"https://clinicaltrials.gov/study/NCT05444465","title":"Evaluation of Safety and Efficacy of a Resorbable Collagen Implant in Treatment of High Grade PArtial ThiCkness Tears; A Prospective, Multicenter, Randomized, Control Trial (IMPACT Study)","has_exemption":false,"start_date":"2022-08-30","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Smith & Nephew, Inc.","sponsor_slug":"smith-nephew-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06006637","publication_url":"https://clinicaltrials.gov/study/NCT06006637","title":"Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder","has_exemption":false,"start_date":"2023-10-17","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"State University of New York - Upstate Medical University","sponsor_slug":"state-university-of-new-york-upstate-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066957","publication_url":"https://clinicaltrials.gov/study/NCT06066957","title":"Open Label Trial of Tolerability and Efficacy of Oral Letermovir for CMV Prophylaxis Among Heart and Lung Transplant Recipients","has_exemption":false,"start_date":"2024-04-04","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662994","publication_url":"https://clinicaltrials.gov/study/NCT06662994","title":"High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy","has_exemption":false,"start_date":"2025-07-07","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Retina Consultants of Orange County","sponsor_slug":"retina-consultants-of-orange-county","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282080","publication_url":"https://clinicaltrials.gov/study/NCT07282080","title":"Discover Better Body Composition With Green Light!","has_exemption":false,"start_date":"2025-08-15","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990906","publication_url":"https://clinicaltrials.gov/study/NCT06990906","title":"BENCHMARK SPERM: A Prospective, Randomized Controlled Study Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)","has_exemption":false,"start_date":"2026-03-15","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"BAIBYS Fertility","sponsor_slug":"baibys-fertility","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05325996","publication_url":"https://clinicaltrials.gov/study/NCT05325996","title":"Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.","has_exemption":false,"start_date":"2022-04-15","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Wills Eye","sponsor_slug":"wills-eye","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671938","publication_url":"https://clinicaltrials.gov/study/NCT06671938","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients With Mild to Moderate Parkinson's Disease on Stable Symptomatic Parkinson's Disease Medication and in Patients With Multiple System Atrophy","has_exemption":false,"start_date":"2024-10-24","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"BioArctic AB","sponsor_slug":"bioarctic-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07016412","publication_url":"https://clinicaltrials.gov/study/NCT07016412","title":"A Phase IIb, Randomized, Double-blind, Placebo- Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ensifentrine-glycopyrrolate Fixed-dose Combination at Two Dose Levels Compared to Glycopyrrolate or Ensifentrine Monotherapy in Subjects With COPD","has_exemption":false,"start_date":"2025-07-31","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA","sponsor_slug":"verona-pharma-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03461120","publication_url":"https://clinicaltrials.gov/study/NCT03461120","title":"Improving Postamputation Functioning by Decreasing Phantom Limb Pain and Opioid Use With Perioperative Continuous Peripheral Nerve Blocks: A Multicenter RCT","has_exemption":false,"start_date":"2018-03-23","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864169","publication_url":"https://clinicaltrials.gov/study/NCT06864169","title":"A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07260695","publication_url":"https://clinicaltrials.gov/study/NCT07260695","title":"Study Evaluating Visual Outcomes in Post-Myopic LASIK Patients After Implantation of the Odyssey Intraocular Lens","has_exemption":false,"start_date":"2025-08-18","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"Center For Sight","sponsor_slug":"center-for-sight","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03437928","publication_url":"https://clinicaltrials.gov/study/NCT03437928","title":"Deep Brain Stimulation (DBS) for Depression Using Directional Current Steering and Individualized Network Targeting","has_exemption":false,"start_date":"2019-08-20","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796570","publication_url":"https://clinicaltrials.gov/study/NCT05796570","title":"A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies","has_exemption":false,"start_date":"2023-04-19","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Franziska Wachter","sponsor_slug":"franziska-wachter","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06104124","publication_url":"https://clinicaltrials.gov/study/NCT06104124","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity","has_exemption":false,"start_date":"2024-01-24","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618612","publication_url":"https://clinicaltrials.gov/study/NCT06618612","title":"A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Organogenesis","sponsor_slug":"organogenesis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694805","publication_url":"https://clinicaltrials.gov/study/NCT06694805","title":"A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN)","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213986","publication_url":"https://clinicaltrials.gov/study/NCT07213986","title":"Pilot Trial of the Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction","has_exemption":false,"start_date":"2026-01-06","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01684397","publication_url":"https://clinicaltrials.gov/study/NCT01684397","title":"A Phase I/II Trial of Pazopanib Alternating With Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma Patients","has_exemption":false,"start_date":"2012-11-21","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04474132","publication_url":"https://clinicaltrials.gov/study/NCT04474132","title":"Feasibility Study for Finger Prick Testing of Presence of Current and or Previous T. Gondii Infection","has_exemption":false,"start_date":"2020-08-13","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04996823","publication_url":"https://clinicaltrials.gov/study/NCT04996823","title":"Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma","has_exemption":false,"start_date":"2021-08-04","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388226","publication_url":"https://clinicaltrials.gov/study/NCT06388226","title":"Leg Heat Therapy to Improve Functional Performance in Heart Failure With Preserved Ejection Fraction (HFpEF)","has_exemption":false,"start_date":"2024-08-15","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303998","publication_url":"https://clinicaltrials.gov/study/NCT07303998","title":"Feasibility and Effect of Remotely Supervised Transcranial Direct Current Stimulation With Chair Yoga for Chronic Knee Pain Management in Older Adults With Alzheimer's Disease and Related Dementias.","has_exemption":false,"start_date":"2025-03-04","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926660","publication_url":"https://clinicaltrials.gov/study/NCT06926660","title":"A Phase II Randomised, Double-blind, Parallel-group, Multicentre, International Trial to Investigate the Safety and Efficacy of Vicadrostat and Empagliflozin Administered With Simultaneous vs Staggered Initiation in Participants With Chronic Kidney Disease at Risk of Kidney Disease Progression","has_exemption":false,"start_date":"2025-07-18","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03815643","publication_url":"https://clinicaltrials.gov/study/NCT03815643","title":"An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies","has_exemption":false,"start_date":"2019-03-22","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305834","publication_url":"https://clinicaltrials.gov/study/NCT04305834","title":"A Phase IIA Trial Assessing the Tolerability of Abemaciclib in Combination With Endocrine Therapy in Patients Age 70 and Older With Hormone Receptor Positive Metastatic Breast Cancer Who Have Progressed on or After Prior CDK 4/6 Inhibition","has_exemption":false,"start_date":"2020-03-25","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626479","publication_url":"https://clinicaltrials.gov/study/NCT04626479","title":"A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (U03): Substudy 03A in First Line Metastatic Participants","has_exemption":false,"start_date":"2020-12-16","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626518","publication_url":"https://clinicaltrials.gov/study/NCT04626518","title":"A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (KEYMAKER-U03): Substudy 03B in Second-Line Metastatic Participants","has_exemption":false,"start_date":"2020-12-17","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660394","publication_url":"https://clinicaltrials.gov/study/NCT06660394","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy, Safety, and Tolerability of LP352 in the Treatment of Seizures in Children and Adults With Dravet Syndrome","has_exemption":false,"start_date":"2024-09-25","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Longboard Pharmaceuticals","sponsor_slug":"longboard-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797869","publication_url":"https://clinicaltrials.gov/study/NCT06797869","title":"Efficacy and Safety of co Administered Cagrilintide and Semaglutide (CagriSema) Once Weekly Versus Placebo in Participants With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy","has_exemption":false,"start_date":"2025-01-29","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220629","publication_url":"https://clinicaltrials.gov/study/NCT07220629","title":"A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide Plus a Reduced Calorie Diet and Increased Physical Activity in Participants With Obesity","has_exemption":false,"start_date":"2025-10-02","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"NodThera Limited","sponsor_slug":"nodthera-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965413","publication_url":"https://clinicaltrials.gov/study/NCT06965413","title":"A Randomized, Double-blind, Placebo-controlled Phase 2 Trial to Assess Efficacy, Safety, and Tolerability of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-08-22","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07120763","publication_url":"https://clinicaltrials.gov/study/NCT07120763","title":"Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures","has_exemption":false,"start_date":"2025-08-22","completion_date":"2026-08-22","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05262400","publication_url":"https://clinicaltrials.gov/study/NCT05262400","title":"A PHASE 1B/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTITUMOR ACTIVITY OF PF-07220060 IN COMBINATION WITH PF-07104091 PLUS ENDOCRINE THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS","has_exemption":false,"start_date":"2022-03-14","completion_date":"2026-08-23","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05758246","publication_url":"https://clinicaltrials.gov/study/NCT05758246","title":"Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial","has_exemption":false,"start_date":"2023-08-23","completion_date":"2026-08-23","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686043","publication_url":"https://clinicaltrials.gov/study/NCT06686043","title":"A Phase 2 Study of HPV L1 Vaccine in Combination With Imiquimod and Metformin in Cervical, Vaginal, and Vulvar Cancers","has_exemption":false,"start_date":"2024-08-23","completion_date":"2026-08-23","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711252","publication_url":"https://clinicaltrials.gov/study/NCT04711252","title":"SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) Plus Palbociclib Versus Anastrozole Plus Palbociclib for the Treatment of Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease","has_exemption":false,"start_date":"2021-01-28","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389449","publication_url":"https://clinicaltrials.gov/study/NCT05389449","title":"A Long-term Extension (LTE) Study to Characterize the Safety and Efficacy of Danicopan as an Add-on Therapy to a Complement Component 5 Inhibitor (C5i) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Previously Treated With Danicopan in an Alexion-sponsored Clinical Study","has_exemption":false,"start_date":"2022-10-28","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161441","publication_url":"https://clinicaltrials.gov/study/NCT06161441","title":"A Phase 2 Peri-Operative Trial of Fianlimab and Cemiplimab in Combination With Chemotherapy Versus Cemiplimab in Combination With Chemotherapy in Patients With Resectable Early Stage (Stage II to IIIB [N2]) NSCLC","has_exemption":false,"start_date":"2024-07-16","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04567303","publication_url":"https://clinicaltrials.gov/study/NCT04567303","title":"A Three-part, Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05132075","publication_url":"https://clinicaltrials.gov/study/NCT05132075","title":"A Randomized, Controlled, Open Label, Phase III Study Evaluating the Efficacy and Safety of JDQ443 Versus Docetaxel in Previously Treated Subjects With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752813","publication_url":"https://clinicaltrials.gov/study/NCT04752813","title":"A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"BPGbio","sponsor_slug":"bpgbio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281989","publication_url":"https://clinicaltrials.gov/study/NCT07281989","title":"Sound Stops Stress Study: Evaluating the WAVwatch Effect","has_exemption":false,"start_date":"2025-08-25","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984627","publication_url":"https://clinicaltrials.gov/study/NCT06984627","title":"An Open-label Phase 2 Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716531","publication_url":"https://clinicaltrials.gov/study/NCT03716531","title":"PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement","has_exemption":false,"start_date":"2019-03-19","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04009512","publication_url":"https://clinicaltrials.gov/study/NCT04009512","title":"Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms","has_exemption":false,"start_date":"2020-10-06","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Matthew Eagleton","sponsor_slug":"matthew-eagleton","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058650","publication_url":"https://clinicaltrials.gov/study/NCT06058650","title":"Pilot Clinical Study to Evaluate Molecular Breast Imaging- Guidance for Sampling of Breast Abnormalities","has_exemption":false,"start_date":"2021-08-26","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554367","publication_url":"https://clinicaltrials.gov/study/NCT05554367","title":"Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2023-12-13","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06791122","publication_url":"https://clinicaltrials.gov/study/NCT06791122","title":"A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia","has_exemption":false,"start_date":"2025-01-23","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06450639","publication_url":"https://clinicaltrials.gov/study/NCT06450639","title":"A Phase II Multicenter, Open-label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Pediatric Patients With Duchenne Muscular Dystrophy (SHIELD DMD)","has_exemption":false,"start_date":"2025-04-04","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05413850","publication_url":"https://clinicaltrials.gov/study/NCT05413850","title":"An Open-label, Multicentre, Integrated Phase 1 & 2 Study to Evaluate the Safety, Tolerability, Radiation Dosimetry and Anti-tumour Activity of Lutetium (177Lu) rhPSMA-10.1 Injection in Men With Metastatic Castrate-resistant Prostate Cancer","has_exemption":false,"start_date":"2022-07-20","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Blue Earth Therapeutics Ltd","sponsor_slug":"blue-earth-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757713","publication_url":"https://clinicaltrials.gov/study/NCT05757713","title":"Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoantibodies and Dysglycemia)","has_exemption":false,"start_date":"2023-07-25","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995523","publication_url":"https://clinicaltrials.gov/study/NCT04995523","title":"Phase I/II, Open-label, Dose Escalation and Dose Expansion Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC","has_exemption":false,"start_date":"2021-09-14","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814693","publication_url":"https://clinicaltrials.gov/study/NCT04814693","title":"A Prospective, Post-Market, Multicenter, Randomized Controlled Trial to Compare the Performance of the EndoRotor® System Versus Conventional Endoscopic Techniques for Direct Endoscopic Necrosectomy of Walled Off Necrosis - The RESOlVE Trial","has_exemption":false,"start_date":"2022-09-02","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Erasmus Medical Center","sponsor_slug":"erasmus-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05634499","publication_url":"https://clinicaltrials.gov/study/NCT05634499","title":"A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer","has_exemption":false,"start_date":"2023-06-27","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225829","publication_url":"https://clinicaltrials.gov/study/NCT07225829","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof of Concept Trial to Investigate the Efficacy and Safety of Intra-articular 4P004 in Subjects With Knee Synovitis and Osteoarthritis","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"4Moving Biotech","sponsor_slug":"4moving-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224607","publication_url":"https://clinicaltrials.gov/study/NCT07224607","title":"A Longitudinal Study Investigating the Effects of Photobiomodulation (PBM) on Cognitive Function and Alzheimer's Disease (AD)-Related Biomarkers in Individuals With Mild Cognitive Impairment (MCI) or Dementia Due to AD","has_exemption":false,"start_date":"2025-12-25","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516808","publication_url":"https://clinicaltrials.gov/study/NCT07516808","title":"PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254171","publication_url":"https://clinicaltrials.gov/study/NCT05254171","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2022-08-08","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Panbela Therapeutics, Inc.","sponsor_slug":"panbela-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849402","publication_url":"https://clinicaltrials.gov/study/NCT05849402","title":"Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282119","publication_url":"https://clinicaltrials.gov/study/NCT07282119","title":"Can EmeraldLED Reshape Your Body With Continued Use?","has_exemption":false,"start_date":"2025-08-29","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04084730","publication_url":"https://clinicaltrials.gov/study/NCT04084730","title":"Ultra-Short External Beam-Based Accelerated Partial Breast Irradiation (APBI): A Phase II Toxicity Study Nested With a Non-inferiority Assessment of APBI in New Patient Cohorts","has_exemption":false,"start_date":"2019-08-30","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04178005","publication_url":"https://clinicaltrials.gov/study/NCT04178005","title":"Cladribine Tablets After Treatment With Natalizumab (CLADRINA)","has_exemption":false,"start_date":"2020-02-19","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03812874","publication_url":"https://clinicaltrials.gov/study/NCT03812874","title":"Phase I/II Study of PTX-9908 Injection As an Inhibitor of Cancer Progression in Patients with Non-resectable Hepatocellular Carcinoma Following Transarterial Chemoembolization Treatment","has_exemption":false,"start_date":"2020-10-06","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"TCM Biotech International Corp.","sponsor_slug":"tcm-biotech-international-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278651","publication_url":"https://clinicaltrials.gov/study/NCT04278651","title":"Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446298","publication_url":"https://clinicaltrials.gov/study/NCT05446298","title":"Phase 2 Randomized Open-label Multicenter Study of Combination of ONC-392 and Pembrolizumab for the Treatment of Patients With Platinum Resistant Ovarian Cancer (PROC)","has_exemption":false,"start_date":"2022-12-22","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"OncoC4, Inc.","sponsor_slug":"oncoc4-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05806164","publication_url":"https://clinicaltrials.gov/study/NCT05806164","title":"Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence","has_exemption":false,"start_date":"2023-06-06","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901233","publication_url":"https://clinicaltrials.gov/study/NCT05901233","title":"Telerehabilitation With Remotely-Supervised tDCS in Progressive Aphasia","has_exemption":false,"start_date":"2023-07-10","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06152575","publication_url":"https://clinicaltrials.gov/study/NCT06152575","title":"A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06452355","publication_url":"https://clinicaltrials.gov/study/NCT06452355","title":"Clinical Trial Designed to Assess the Safety and Effectiveness of the KOKO™ Device In Treating Primary Abnormal Postpartum Uterine Bleeding (\"APUB\") or Hemorrhage (\"PPH\")","has_exemption":false,"start_date":"2024-08-29","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"KOKO Medical Inc.","sponsor_slug":"koko-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671692","publication_url":"https://clinicaltrials.gov/study/NCT05671692","title":"Novel Intervention for Chronic Complex TBI in OEF/OIF/OND Veterans","has_exemption":false,"start_date":"2024-09-06","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Christine Marx, MD","sponsor_slug":"christine-marx-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861478","publication_url":"https://clinicaltrials.gov/study/NCT06861478","title":"In-Hospital Morbidity Associated With Proton Pump Inhibitors in Acute Variceal Bleeding and Chronic Liver Disease Treatment","has_exemption":false,"start_date":"2024-10-20","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Universidad Autonoma de Nuevo Leon","sponsor_slug":"universidad-autonoma-de-nuevo-leon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06451614","publication_url":"https://clinicaltrials.gov/study/NCT06451614","title":"SpaceIT Hydrogel System for Perirectal Spacing in Subjects With Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT)","has_exemption":false,"start_date":"2024-10-30","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588595","publication_url":"https://clinicaltrials.gov/study/NCT06588595","title":"Comparison of ABCD-GENE Score-Guided Versus Unguided DAPT De-Escalation: A Prospective Randomized Pharmacodynamic Study in Patients Undergoing PCI The Switching Antiplatelet-9 (SWAP-9) Study","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769659","publication_url":"https://clinicaltrials.gov/study/NCT06769659","title":"A Single-center, Double-blind, Placebo-controlled Crossover Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures","has_exemption":false,"start_date":"2025-03-11","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"NeuroPro Therapeutics, Inc.","sponsor_slug":"neuropro-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06964373","publication_url":"https://clinicaltrials.gov/study/NCT06964373","title":"Cervical Ripening Balloon for Same-Day Cervical Preparation for Second Trimester Termination","has_exemption":false,"start_date":"2025-04-08","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285850","publication_url":"https://clinicaltrials.gov/study/NCT07285850","title":"The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD Background: a Dual Arm, Multicenter, Randomized Controlled Study","has_exemption":false,"start_date":"2025-10-20","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Eastern Hepatobiliary Surgery Hospital","sponsor_slug":"eastern-hepatobiliary-surgery-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217743","publication_url":"https://clinicaltrials.gov/study/NCT07217743","title":"Prospective, Single Center, Open-label Study Assessing Impact of Poly-L-lactic Acid on Adipogenesis in Patients on Glucagon-like Peptide-1 Agonists","has_exemption":false,"start_date":"2025-10-27","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226011","publication_url":"https://clinicaltrials.gov/study/NCT07226011","title":"Accelerated High-Dose tDCS for Depression: An Open-Label Outpatient Pilot Study","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07354139","publication_url":"https://clinicaltrials.gov/study/NCT07354139","title":"Examining Speech Production Errors in Stuttering Through High Definition - Transcranial Direct Current Stimulation","has_exemption":false,"start_date":"2026-03-17","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432750","publication_url":"https://clinicaltrials.gov/study/NCT07432750","title":"Comparing Efficacy of Osteopathic Manipulation vs. Wrist Immobilization for Carpal Tunnel Syndrome Using Magnetic Resonance Imaging and Patient Perception","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"New York Institute of Technology","sponsor_slug":"new-york-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07749963","publication_url":"https://clinicaltrials.gov/study/NCT07749963","title":"A Data Collection Study to Collect Blood Pressure (BP) Data Using the CardiacSense BP Watch and CardiacSense Pillow Systems for Algorithm Development","has_exemption":false,"start_date":"2026-07-21","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"CardiacSense Ltd.","sponsor_slug":"cardiacsense-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01798407","publication_url":"https://clinicaltrials.gov/study/NCT01798407","title":"A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression","has_exemption":false,"start_date":"2013-02-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Wayne Goodman MD","sponsor_slug":"wayne-goodman-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01920737","publication_url":"https://clinicaltrials.gov/study/NCT01920737","title":"A Novel \"Pediatric-Inspired\" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2013-08-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01983241","publication_url":"https://clinicaltrials.gov/study/NCT01983241","title":"A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency","has_exemption":false,"start_date":"2013-11-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02177578","publication_url":"https://clinicaltrials.gov/study/NCT02177578","title":"A Randomized Phase II Study of Subventricular Zone (SVZ) Irradiation Plus Temozolomide in Newly Diagnosed Glioblastoma Multiforme","has_exemption":false,"start_date":"2014-07-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844764","publication_url":"https://clinicaltrials.gov/study/NCT02844764","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Hip","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844751","publication_url":"https://clinicaltrials.gov/study/NCT02844751","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Knee","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844738","publication_url":"https://clinicaltrials.gov/study/NCT02844738","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02538198","publication_url":"https://clinicaltrials.gov/study/NCT02538198","title":"Lenalidomide Maintenance in Plasma Cell Myeloma","has_exemption":false,"start_date":"2015-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02610855","publication_url":"https://clinicaltrials.gov/study/NCT02610855","title":"Effect of Treatment on Activity and Muscle Function in Pediatric Patients With Scoliosis (SAMUS SCOLI)","has_exemption":false,"start_date":"2015-11-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02792582","publication_url":"https://clinicaltrials.gov/study/NCT02792582","title":"A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection","has_exemption":false,"start_date":"2016-06-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01512888","publication_url":"https://clinicaltrials.gov/study/NCT01512888","title":"A Pilot Feasibility Study of Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Using a Self-Inactivating Lentiviral Vector to Transduce Autologous CD34+ Hematopoietic Cells","has_exemption":false,"start_date":"2016-08-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02954874","publication_url":"https://clinicaltrials.gov/study/NCT02954874","title":"A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With &gt;/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2017-01-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02849496","publication_url":"https://clinicaltrials.gov/study/NCT02849496","title":"A Phase II Open-Label, Randomized Study of PARP Inhibition (Olaparib) Either Alone or in Combination With Anti-PD-L1 Therapy (Atezolizumab; MPDL3280A) in Homologous DNA Repair (HDR) Deficient, Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer","has_exemption":false,"start_date":"2017-03-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03347786","publication_url":"https://clinicaltrials.gov/study/NCT03347786","title":"Intraarterial Verapamil for Neuroprotection in Ischemic Stroke","has_exemption":false,"start_date":"2017-04-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Global Neurosciences Institute","sponsor_slug":"global-neurosciences-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03257163","publication_url":"https://clinicaltrials.gov/study/NCT03257163","title":"A Phase II Study of Preoperative Pembrolizumab for Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer Followed by Chemotherapy and Chemoradiation With Pembrolizumab","has_exemption":false,"start_date":"2017-09-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03328078","publication_url":"https://clinicaltrials.gov/study/NCT03328078","title":"An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma","has_exemption":false,"start_date":"2017-12-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Curis, Inc.","sponsor_slug":"curis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03079999","publication_url":"https://clinicaltrials.gov/study/NCT03079999","title":"Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas","has_exemption":false,"start_date":"2018-06-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03618537","publication_url":"https://clinicaltrials.gov/study/NCT03618537","title":"Ixazomib Maintenance Following Initial Therapy in Patients With Immunoglobulin Light Chain (AL) Amyloidosis","has_exemption":false,"start_date":"2018-08-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03526432","publication_url":"https://clinicaltrials.gov/study/NCT03526432","title":"A Phase II, Single Arm Study of Atezolizumab + Bevacizumab in Women With Advanced, Recurrent or Persistent Endometrial Cancer","has_exemption":false,"start_date":"2018-08-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03631017","publication_url":"https://clinicaltrials.gov/study/NCT03631017","title":"Safety, Biodistribution and Radiation Dosimetry of [18F]PARPi","has_exemption":false,"start_date":"2018-08-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03619850","publication_url":"https://clinicaltrials.gov/study/NCT03619850","title":"A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)","has_exemption":false,"start_date":"2018-08-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AMAG Pharmaceuticals, Inc.","sponsor_slug":"amag-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03635892","publication_url":"https://clinicaltrials.gov/study/NCT03635892","title":"A Phase 2 Open-Label Study of Nivolumab Combined With Cabozantinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (CA209-9KU)","has_exemption":false,"start_date":"2018-08-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03554356","publication_url":"https://clinicaltrials.gov/study/NCT03554356","title":"Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)","has_exemption":false,"start_date":"2018-09-04","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03539744","publication_url":"https://clinicaltrials.gov/study/NCT03539744","title":"A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2018-10-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03774446","publication_url":"https://clinicaltrials.gov/study/NCT03774446","title":"A Phase 2 Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease","has_exemption":false,"start_date":"2018-11-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03816163","publication_url":"https://clinicaltrials.gov/study/NCT03816163","title":"A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2019-03-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03713424","publication_url":"https://clinicaltrials.gov/study/NCT03713424","title":"An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction","has_exemption":false,"start_date":"2019-03-26","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03575195","publication_url":"https://clinicaltrials.gov/study/NCT03575195","title":"Microbiota Intervention to Change the Response of Parkinson's Disease","has_exemption":false,"start_date":"2019-07-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04206540","publication_url":"https://clinicaltrials.gov/study/NCT04206540","title":"Effect of Electrical Stimulation of the Auricular Branch of the Vagus Nerve (ABVN) on Cervical Vagus Nerve Compound Nerve Action Potentials(CNAPs)","has_exemption":false,"start_date":"2019-07-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03991962","publication_url":"https://clinicaltrials.gov/study/NCT03991962","title":"Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2019-09-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04045665","publication_url":"https://clinicaltrials.gov/study/NCT04045665","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","has_exemption":false,"start_date":"2019-12-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04135846","publication_url":"https://clinicaltrials.gov/study/NCT04135846","title":"A Focus on Alpha-1 Blockade as a Novel Pharmacological Treatment for AUD","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03989206","publication_url":"https://clinicaltrials.gov/study/NCT03989206","title":"A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2019-12-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04013854","publication_url":"https://clinicaltrials.gov/study/NCT04013854","title":"Adjuvant Nivolumab or Ipilimumab + Nivolumab Determined By Pathological Response To A Single Dose Of Neoadjvuant Nivolumab","has_exemption":false,"start_date":"2020-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04267003","publication_url":"https://clinicaltrials.gov/study/NCT04267003","title":"Transcranial Direct Current Stimulation (tDCS) Studies of Cognition, Oscillations and GABA Levels in Schizophrenia","has_exemption":false,"start_date":"2020-01-09","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04110730","publication_url":"https://clinicaltrials.gov/study/NCT04110730","title":"The Influence of 3D Printed Prostheses on Neural Activation Patterns of the Primary Motor Cortex in Children With Unilateral Congenital Upper-limb Reductions","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04467671","publication_url":"https://clinicaltrials.gov/study/NCT04467671","title":"Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03764098","publication_url":"https://clinicaltrials.gov/study/NCT03764098","title":"Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders","has_exemption":false,"start_date":"2020-08-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04503265","publication_url":"https://clinicaltrials.gov/study/NCT04503265","title":"A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients With Advanced Malignancies","has_exemption":false,"start_date":"2020-08-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AtlasMedx, Incorporated","sponsor_slug":"atlasmedx-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04514653","publication_url":"https://clinicaltrials.gov/study/NCT04514653","title":"A Phase 2, Randomized, Dose-escalation, Ranibizumab-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered Via One or Two Suprachoroidal Space (SCS) Injections in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)","has_exemption":false,"start_date":"2020-08-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04497961","publication_url":"https://clinicaltrials.gov/study/NCT04497961","title":"Daratumumab Versus Lenalidomide Maintenance Therapy for Multiple Myeloma: A Randomized Pilot Study Comparing Patient-Reported Health Related Quality of Life Measures With a Plant Based Nutrition Intervention Sub Study (NUTRIVENTION-4)","has_exemption":false,"start_date":"2020-08-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04219280","publication_url":"https://clinicaltrials.gov/study/NCT04219280","title":"Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04066192","publication_url":"https://clinicaltrials.gov/study/NCT04066192","title":"A Pharmacogenetic Human Laboratory Investigation of Brexpiprazole in Alcohol Use Disorder","has_exemption":false,"start_date":"2020-10-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04807894","publication_url":"https://clinicaltrials.gov/study/NCT04807894","title":"Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo","has_exemption":false,"start_date":"2020-11-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Maimonides Medical Center","sponsor_slug":"maimonides-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04454528","publication_url":"https://clinicaltrials.gov/study/NCT04454528","title":"Preoperative Use of Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer","has_exemption":false,"start_date":"2020-12-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04388839","publication_url":"https://clinicaltrials.gov/study/NCT04388839","title":"Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04467437","publication_url":"https://clinicaltrials.gov/study/NCT04467437","title":"Transcutaneous Spinal Stimulation With Intensive Gait Training for Individuals With Neurologic Conditions","has_exemption":false,"start_date":"2021-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04875052","publication_url":"https://clinicaltrials.gov/study/NCT04875052","title":"The Effects of Vibratory Stimuli on Joint Health and Post-traumatic Osteoarthritis Risk Following Anterior Cruciate Ligament Injury","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04786548","publication_url":"https://clinicaltrials.gov/study/NCT04786548","title":"A Precision Medicine Approach to OCD Treatment: Targeting Neuroinflammation","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833907","publication_url":"https://clinicaltrials.gov/study/NCT04833907","title":"Phase 1/2, Open Label, Sequential Cohort Study of a Single Intracranial Dose of AVASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Myrtelle Inc.","sponsor_slug":"myrtelle-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04704934","publication_url":"https://clinicaltrials.gov/study/NCT04704934","title":"A Phase 3, Multicenter, 2-Arm Randomized, Open-Label Study of Trastuzumab Deruxtecan in Subjects With HER2-Positive Metastatic and/or Unresectable Gastric or Gastro-Esophageal Junction (GEJ) Adenocarcinoma Subjects Who Have Progressed on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)","has_exemption":false,"start_date":"2021-05-21","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573231","publication_url":"https://clinicaltrials.gov/study/NCT04573231","title":"Evaluation of Prostate Specific Membrane Antigen (PSMA) in HER2-negative, Androgen Receptor (AR)-Positive Metastatic Breast Cancer With 18F-DCFPyL PSMA-based PET/CT","has_exemption":false,"start_date":"2021-05-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04545424","publication_url":"https://clinicaltrials.gov/study/NCT04545424","title":"Cooling to Help Injured Lungs (CHILL) Phase IIB Randomized Control Trial of Therapeutic Hypothermia in Patients With ARDS","has_exemption":false,"start_date":"2021-06-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04764331","publication_url":"https://clinicaltrials.gov/study/NCT04764331","title":"A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia.","has_exemption":false,"start_date":"2021-07-06","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04087629","publication_url":"https://clinicaltrials.gov/study/NCT04087629","title":"Post-marketing Surveillance of StrataCTX® Flexible Wound Dressing for Use as a Steroid Sparing Agent","has_exemption":false,"start_date":"2021-07-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625127","publication_url":"https://clinicaltrials.gov/study/NCT04625127","title":"GaitBetter: Motor and Cognitive Training for Gait Rehabilitation and Falls Prevention in Stroke Survivors.","has_exemption":false,"start_date":"2021-07-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04585490","publication_url":"https://clinicaltrials.gov/study/NCT04585490","title":"Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC","has_exemption":false,"start_date":"2021-08-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Maximilian Diehn","sponsor_slug":"maximilian-diehn","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011383","publication_url":"https://clinicaltrials.gov/study/NCT05011383","title":"High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency","has_exemption":false,"start_date":"2021-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04730609","publication_url":"https://clinicaltrials.gov/study/NCT04730609","title":"Dexmedetomidine for Treatment of Shivering During Scheduled Elective Cesarean Delivery: Determining the Optimal Dose","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04677816","publication_url":"https://clinicaltrials.gov/study/NCT04677816","title":"Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients Receiving Neoadjuvant Chemotherapy for Operable Triple Negative Breast Cancer","has_exemption":false,"start_date":"2021-10-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05077774","publication_url":"https://clinicaltrials.gov/study/NCT05077774","title":"Harmony TPV Post-Approval Study (Harmony PAS2)","has_exemption":false,"start_date":"2021-10-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05027477","publication_url":"https://clinicaltrials.gov/study/NCT05027477","title":"Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Profound Medical Inc.","sponsor_slug":"profound-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05163041","publication_url":"https://clinicaltrials.gov/study/NCT05163041","title":"Phase 1/2 Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT7480 in Patients With Nectin-4 Associated Advanced Malignancies","has_exemption":false,"start_date":"2021-11-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"BicycleTx Limited","sponsor_slug":"bicycletx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04758624","publication_url":"https://clinicaltrials.gov/study/NCT04758624","title":"Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract","has_exemption":false,"start_date":"2021-12-04","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05077904","publication_url":"https://clinicaltrials.gov/study/NCT05077904","title":"A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","has_exemption":false,"start_date":"2021-12-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05051436","publication_url":"https://clinicaltrials.gov/study/NCT05051436","title":"The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics","has_exemption":false,"start_date":"2021-12-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Philip Kern","sponsor_slug":"philip-kern","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06000592","publication_url":"https://clinicaltrials.gov/study/NCT06000592","title":"Safety, Feasibility, and Efficacy of Transcutaneous Spinal Cord Stimulation on Stabilizing Blood Pressure for Acute Inpatients With Spinal Cord Injury","has_exemption":false,"start_date":"2022-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Jill M. Wecht, Ed.D.","sponsor_slug":"jill-m-wecht-edd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04917809","publication_url":"https://clinicaltrials.gov/study/NCT04917809","title":"A Phase 2 \"Window of Opportunity\" Trial of Targeted Therapy With Erdafitinib in Patients With Recurrent FGFR3-Altered Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2022-02-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05289167","publication_url":"https://clinicaltrials.gov/study/NCT05289167","title":"A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2022-03-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05302999","publication_url":"https://clinicaltrials.gov/study/NCT05302999","title":"Feasibility of Early Gabapentin as an Intervention for Neurorecovery","has_exemption":false,"start_date":"2022-03-14","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"MetroHealth Medical Center","sponsor_slug":"metrohealth-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05264545","publication_url":"https://clinicaltrials.gov/study/NCT05264545","title":"Prospective, Multicenter, Non-randomized, Controlled Clinical Study Utilizing Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"McGuire Institute","sponsor_slug":"mcguire-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05300451","publication_url":"https://clinicaltrials.gov/study/NCT05300451","title":"A Phase II Prospective Study Evaluating the Role of Daratumumab in HLA Desensitization Prior to Transplantation","has_exemption":false,"start_date":"2022-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Barry A. Boilson","sponsor_slug":"barry-a-boilson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05140941","publication_url":"https://clinicaltrials.gov/study/NCT05140941","title":"Safety, Tolerability, and Outcomes of Velpatasvir/SofosbuviR in Treatment of Chronic Hepatitis C Virus During Pregnancy (STORC)","has_exemption":false,"start_date":"2022-04-04","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Catherine Anne Chappell","sponsor_slug":"catherine-anne-chappell","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05590637","publication_url":"https://clinicaltrials.gov/study/NCT05590637","title":"A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease","has_exemption":false,"start_date":"2022-04-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04866472","publication_url":"https://clinicaltrials.gov/study/NCT04866472","title":"Comparison of Video Laryngoscope (VLS) With GlideRite Ridge Stylet vs Video Laryngoscope With the TCI Articulating Indroducer for Endotracheal Intubation in Predicted Difficult Airways. A Prospective Randomized Control Trial","has_exemption":false,"start_date":"2022-04-26","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285566","publication_url":"https://clinicaltrials.gov/study/NCT05285566","title":"A Phase IV Randomized, Single-Blind Trial of Liposomal Bupivacaine (Exparel®) for Pain Control in Costal Cartilage Harvest","has_exemption":false,"start_date":"2022-05-04","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05201469","publication_url":"https://clinicaltrials.gov/study/NCT05201469","title":"A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis (ITN091AI)","has_exemption":false,"start_date":"2022-05-16","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05111288","publication_url":"https://clinicaltrials.gov/study/NCT05111288","title":"Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia","has_exemption":false,"start_date":"2022-05-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04863950","publication_url":"https://clinicaltrials.gov/study/NCT04863950","title":"A Phase II, Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma","has_exemption":false,"start_date":"2022-05-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05251714","publication_url":"https://clinicaltrials.gov/study/NCT05251714","title":"A Dose-confirming Study of CFI-402257 as a Single Agent in Advanced Solid Tumors and in Combination With Fulvestrant in Patients With ER+/HER2- Advanced Breast Cancer After Disease Progression on Prior CDK4/6 and Endocrine Therapy","has_exemption":false,"start_date":"2022-05-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Treadwell Therapeutics, Inc","sponsor_slug":"treadwell-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05211570","publication_url":"https://clinicaltrials.gov/study/NCT05211570","title":"A Phase 1/2 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Daily Intravenous AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AB Science","sponsor_slug":"ab-science","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05178069","publication_url":"https://clinicaltrials.gov/study/NCT05178069","title":"Lactobacillus Rhamnosus GG: A Novel Probiotic Therapy for Treating Alcohol Use Disorder","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05089370","publication_url":"https://clinicaltrials.gov/study/NCT05089370","title":"Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab as a Strategy to Enhance the Efficacy of Immune Checkpoint Blockade in Unresectable or Metastatic Mucosal Melanoma","has_exemption":false,"start_date":"2022-06-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580614","publication_url":"https://clinicaltrials.gov/study/NCT05580614","title":"Pairing tVNS and Exposure and Response Prevention to Improve Symptoms of OCD","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03616236","publication_url":"https://clinicaltrials.gov/study/NCT03616236","title":"Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Friends Research Institute, Inc.","sponsor_slug":"friends-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05515575","publication_url":"https://clinicaltrials.gov/study/NCT05515575","title":"Phase II Study of Niraparib in Soft Tissue Sarcoma Patients With Altered DNA Damage Repair","has_exemption":false,"start_date":"2022-08-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05308264","publication_url":"https://clinicaltrials.gov/study/NCT05308264","title":"An Open-label, Phase 1b Study of R289, an IRAK1/4 Inhibitor, in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) Who Are Relapsed/Refractory/Resistant to Prior Therapies","has_exemption":false,"start_date":"2022-09-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05543681","publication_url":"https://clinicaltrials.gov/study/NCT05543681","title":"A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease","has_exemption":false,"start_date":"2022-10-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"IGC Pharma LLC","sponsor_slug":"igc-pharma-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04933539","publication_url":"https://clinicaltrials.gov/study/NCT04933539","title":"A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma","has_exemption":false,"start_date":"2022-10-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05568095","publication_url":"https://clinicaltrials.gov/study/NCT05568095","title":"A Randomized, Open-Label, Multicenter Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2022-11-21","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05225233","publication_url":"https://clinicaltrials.gov/study/NCT05225233","title":"Transcranial Direct Current Stimulation (tDCS) With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity: A Clinical Trial","has_exemption":false,"start_date":"2022-11-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05490472","publication_url":"https://clinicaltrials.gov/study/NCT05490472","title":"A Phase 1/2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-2485 in Adult Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Jacobio Pharmaceuticals Co., Ltd.","sponsor_slug":"jacobio-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05538533","publication_url":"https://clinicaltrials.gov/study/NCT05538533","title":"A Phase I Study of Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)","has_exemption":false,"start_date":"2023-01-06","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05480995","publication_url":"https://clinicaltrials.gov/study/NCT05480995","title":"Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone Positron Emission Tomography-Magnetic Resonance Imaging (PET / MRI)","has_exemption":false,"start_date":"2023-01-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672927","publication_url":"https://clinicaltrials.gov/study/NCT05672927","title":"Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age","has_exemption":false,"start_date":"2023-01-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05498272","publication_url":"https://clinicaltrials.gov/study/NCT05498272","title":"A Phase 2 Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations (NePtune)","has_exemption":false,"start_date":"2023-02-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rana McKay, MD","sponsor_slug":"rana-mckay-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05428007","publication_url":"https://clinicaltrials.gov/study/NCT05428007","title":"A Phase II Study of the Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma","has_exemption":false,"start_date":"2023-02-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05727787","publication_url":"https://clinicaltrials.gov/study/NCT05727787","title":"vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC","has_exemption":false,"start_date":"2023-02-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281521","publication_url":"https://clinicaltrials.gov/study/NCT07281521","title":"Safety & Effectiveness of the CardioWave Pulsed Field Ablation System With the QuickShot Nav Large-Area Focal Catheter for Ablation of Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2023-02-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05595577","publication_url":"https://clinicaltrials.gov/study/NCT05595577","title":"Improving Exercise Capacity With a Tailored Physical Activity Intervention in Lymphoma and Breast Cancer Patients Undergoing Treatment","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669482","publication_url":"https://clinicaltrials.gov/study/NCT05669482","title":"A Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination With Avutometinib (VS-6766) and Defactinib in Patients With Previously Untreated Metastatic Adenocarcinoma of the Pancreas","has_exemption":false,"start_date":"2023-03-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801861","publication_url":"https://clinicaltrials.gov/study/NCT05801861","title":"Modulating Spatial Processing During Goal-directed Navigation Using Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05550194","publication_url":"https://clinicaltrials.gov/study/NCT05550194","title":"VZV in the Enteric Nervous System: Pathogenesis and Consequences","has_exemption":false,"start_date":"2023-03-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05611931","publication_url":"https://clinicaltrials.gov/study/NCT05611931","title":"A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma","has_exemption":false,"start_date":"2023-04-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938725","publication_url":"https://clinicaltrials.gov/study/NCT05938725","title":"KYSA-1: A Phase 1/2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis","has_exemption":false,"start_date":"2023-04-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Kyverna Therapeutics","sponsor_slug":"kyverna-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869500","publication_url":"https://clinicaltrials.gov/study/NCT05869500","title":"Left Bundle Area Pacing Vs. Right Ventricular Pacing in Patients With Normal Left Ventricular Function -The Boston Pace Study","has_exemption":false,"start_date":"2023-05-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05408546","publication_url":"https://clinicaltrials.gov/study/NCT05408546","title":"Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism","has_exemption":false,"start_date":"2023-05-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Translational Sciences, Inc.","sponsor_slug":"translational-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976074","publication_url":"https://clinicaltrials.gov/study/NCT05976074","title":"A Prospective Feasibility Study Evaluating the Use of Wearable Devices to Quantify Tolerance to Deep Brain Stimulation in Essential Tremor Patients","has_exemption":false,"start_date":"2023-07-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05783596","publication_url":"https://clinicaltrials.gov/study/NCT05783596","title":"A Phase 2 Study of Glofitamab and Obinutuzumab for First-line Treatment of Follicular Lymphoma and Marginal Zone Lymphoma","has_exemption":false,"start_date":"2023-07-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Reid Merryman, MD","sponsor_slug":"reid-merryman-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05495906","publication_url":"https://clinicaltrials.gov/study/NCT05495906","title":"A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV","has_exemption":false,"start_date":"2023-07-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797610","publication_url":"https://clinicaltrials.gov/study/NCT05797610","title":"A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sefaxersen, an Antisense Inhibitor of Complement Factor B, in Patients With Primary IgA Nephropathy at High Risk of Progression","has_exemption":false,"start_date":"2023-08-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05953961","publication_url":"https://clinicaltrials.gov/study/NCT05953961","title":"Randomized Study of Therapshere 90-Yittrium Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia","has_exemption":false,"start_date":"2023-08-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Ochsner Health System","sponsor_slug":"ochsner-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05654506","publication_url":"https://clinicaltrials.gov/study/NCT05654506","title":"A Multi-center Open-label Trial Evaluating the Efficacy and Safety of Daratumumab SC in Treatment of Patients With Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits (PGNMID)","has_exemption":false,"start_date":"2023-08-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06081894","publication_url":"https://clinicaltrials.gov/study/NCT06081894","title":"A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2023-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cytokinetics","sponsor_slug":"cytokinetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06194838","publication_url":"https://clinicaltrials.gov/study/NCT06194838","title":"Clinical Outcomes Associated With At Home Use of Non-Powered vs. Powered Prosthetic Knees by K2-level Individuals With Transfemoral Amputations","has_exemption":false,"start_date":"2023-09-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Liberating Technologies, Inc.","sponsor_slug":"liberating-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554380","publication_url":"https://clinicaltrials.gov/study/NCT05554380","title":"Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With PTEN/AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548426","publication_url":"https://clinicaltrials.gov/study/NCT05548426","title":"Pilot Study of Linezolid for Early Syphilis Treatment","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05382403","publication_url":"https://clinicaltrials.gov/study/NCT05382403","title":"Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage: a Multicenter Randomized Trial","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055920","publication_url":"https://clinicaltrials.gov/study/NCT06055920","title":"PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism","has_exemption":false,"start_date":"2023-11-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Inari Medical","sponsor_slug":"inari-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04759274","publication_url":"https://clinicaltrials.gov/study/NCT04759274","title":"Diuretic Tuner Clinical Decision Support Mobile Device Application for Diuretic Titration in Hypervolemic States","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05935358","publication_url":"https://clinicaltrials.gov/study/NCT05935358","title":"Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study (NuPOWER)","has_exemption":false,"start_date":"2023-11-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Octapharma","sponsor_slug":"octapharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088914","publication_url":"https://clinicaltrials.gov/study/NCT06088914","title":"Behavioral and Neural Correlates of Post-Stroke Fatigue","has_exemption":false,"start_date":"2023-12-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Texas Woman's University","sponsor_slug":"texas-womans-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995535","publication_url":"https://clinicaltrials.gov/study/NCT05995535","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","has_exemption":false,"start_date":"2024-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06306157","publication_url":"https://clinicaltrials.gov/study/NCT06306157","title":"Low Dose Naltrexone (LDN) Therapy for Complex Regional Pain Syndrome (CRPS): A Feasibility Study","has_exemption":false,"start_date":"2024-01-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116916","publication_url":"https://clinicaltrials.gov/study/NCT06116916","title":"A Phase 2, Multicenter, Randomized, Double-Masked, Parallel-Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Diabetic Macular Edema","has_exemption":false,"start_date":"2024-01-09","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Kyowa Kirin Co., Ltd.","sponsor_slug":"kyowa-kirin-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116890","publication_url":"https://clinicaltrials.gov/study/NCT06116890","title":"A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Kyowa Kirin Co., Ltd.","sponsor_slug":"kyowa-kirin-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888428","publication_url":"https://clinicaltrials.gov/study/NCT05888428","title":"Regulatory Clearance of a Rehabilitation System for Individuals With Upper Limb Loss","has_exemption":false,"start_date":"2024-02-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901519","publication_url":"https://clinicaltrials.gov/study/NCT05901519","title":"A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260722","publication_url":"https://clinicaltrials.gov/study/NCT06260722","title":"A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04880707","publication_url":"https://clinicaltrials.gov/study/NCT04880707","title":"Myogenous Face Pain Following Third Molar Extractions Under Intravenous Sedation","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06158113","publication_url":"https://clinicaltrials.gov/study/NCT06158113","title":"Efficacy and Safety of Baricitinib for the Treatment of Oral Lichen Planus: A Proof-of-Concept Study","has_exemption":false,"start_date":"2024-03-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07698353","publication_url":"https://clinicaltrials.gov/study/NCT07698353","title":"A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent","has_exemption":false,"start_date":"2024-04-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Aquea Health, Inc.","sponsor_slug":"aquea-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06067503","publication_url":"https://clinicaltrials.gov/study/NCT06067503","title":"Integrating Minimally Invasive Biomarkers of Estrogen Signaling to Detect Endocrine Therapy Resistance in Metastatic Invasive Lobular Breast Cancer","has_exemption":false,"start_date":"2024-04-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411288","publication_url":"https://clinicaltrials.gov/study/NCT06411288","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1","has_exemption":false,"start_date":"2024-05-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06336863","publication_url":"https://clinicaltrials.gov/study/NCT06336863","title":"An Extension Protocol for Subjects Previously Enrolled in the \"Use of Donor Derived-cell Free DNA (AlloSure) and Gene Expression Profiling (AlloMap Kidney) to Facilitate Belatacept Monotherapy in Kidney Transplant Patients\"","has_exemption":false,"start_date":"2024-06-14","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06389136","publication_url":"https://clinicaltrials.gov/study/NCT06389136","title":"A Phase 3b/4 Randomized, Open-label, Efficacy Assessor-Blinded Study, to Evaluate the Efficacy and Safety of Upadacitinib for the Treatment of Adult Subjects With Moderate to Severe Atopic Dermatitis and Inadequate Response to Dupilumab (SWITCH-UP)","has_exemption":false,"start_date":"2024-06-14","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05935826","publication_url":"https://clinicaltrials.gov/study/NCT05935826","title":"Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)","has_exemption":false,"start_date":"2024-06-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06102941","publication_url":"https://clinicaltrials.gov/study/NCT06102941","title":"Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children","has_exemption":false,"start_date":"2024-06-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06527365","publication_url":"https://clinicaltrials.gov/study/NCT06527365","title":"An Open-Label Multi-Dose Study to Evaluate the Safety and Efficacy of VDPHL01 in Male and Female Subjects With Androgenetic Alopecia","has_exemption":false,"start_date":"2024-07-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Veradermics, Inc.","sponsor_slug":"veradermics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05923606","publication_url":"https://clinicaltrials.gov/study/NCT05923606","title":"State-dependent Modulation of Interactions of Theta and Gamma Rhythms in Working Memory","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695884","publication_url":"https://clinicaltrials.gov/study/NCT06695884","title":"Determining the Optimal Pulse Protocol for TMS Induced Change in Reward Positivity","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513038","publication_url":"https://clinicaltrials.gov/study/NCT07513038","title":"Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293352","publication_url":"https://clinicaltrials.gov/study/NCT06293352","title":"Durable, Real-component Antibiotic Spacers vs All-cement Articulating Spacers for the Treatment of Periprosthetic Knee Infection","has_exemption":false,"start_date":"2024-08-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06360380","publication_url":"https://clinicaltrials.gov/study/NCT06360380","title":"REFORM-HF™ Reducing Fluid Overload Using Renal Independent systeM in Heart Failure Patients","has_exemption":false,"start_date":"2024-08-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AquaPass Medical Ltd.","sponsor_slug":"aquapass-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05632315","publication_url":"https://clinicaltrials.gov/study/NCT05632315","title":"A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041594","publication_url":"https://clinicaltrials.gov/study/NCT06041594","title":"Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Innova Vascular, Inc.","sponsor_slug":"innova-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033950","publication_url":"https://clinicaltrials.gov/study/NCT06033950","title":"A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)","has_exemption":false,"start_date":"2024-08-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Colorado Prevention Center","sponsor_slug":"colorado-prevention-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569329","publication_url":"https://clinicaltrials.gov/study/NCT06569329","title":"Bacterial Reduction After Supplementary Disinfection Procedures in Infected Root Canals","has_exemption":false,"start_date":"2024-08-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Abhishek Parolia","sponsor_slug":"abhishek-parolia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06556368","publication_url":"https://clinicaltrials.gov/study/NCT06556368","title":"A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)","has_exemption":false,"start_date":"2024-08-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05330182","publication_url":"https://clinicaltrials.gov/study/NCT05330182","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence","has_exemption":false,"start_date":"2024-08-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Lumen Bioscience, Inc.","sponsor_slug":"lumen-bioscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06582771","publication_url":"https://clinicaltrials.gov/study/NCT06582771","title":"A Phase 2 Study of First-line Sotorasib for Patients With Advanced KRAS G12C-mutant Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2024-08-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07678060","publication_url":"https://clinicaltrials.gov/study/NCT07678060","title":"Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06633978","publication_url":"https://clinicaltrials.gov/study/NCT06633978","title":"A Pilot Study of the Impact of Personalized Digital Meditation on Improving Sleep and Reducing Stress in MCI","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06496750","publication_url":"https://clinicaltrials.gov/study/NCT06496750","title":"NIDA CTN-0132 Randomized, Double-Blind, Active Placebo-Controlled Trial of Ketamine for Methamphetamine Use Disorder (KMD)","has_exemption":false,"start_date":"2024-09-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06633952","publication_url":"https://clinicaltrials.gov/study/NCT06633952","title":"Accelerating Cognitive Gains From Digital Meditation With Noninvasive Brain Stimulation: A Pilot Study in MCI","has_exemption":false,"start_date":"2024-09-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553027","publication_url":"https://clinicaltrials.gov/study/NCT06553027","title":"Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Complications","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cerevance","sponsor_slug":"cerevance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04209842","publication_url":"https://clinicaltrials.gov/study/NCT04209842","title":"Utilization of Endoscopically Placed Intra-gastric Balloon in Obese and Morbid Obese Adolescents Combined With Behavioral Support","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06656416","publication_url":"https://clinicaltrials.gov/study/NCT06656416","title":"A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode","has_exemption":false,"start_date":"2024-10-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Alto Neuroscience","sponsor_slug":"alto-neuroscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06581575","publication_url":"https://clinicaltrials.gov/study/NCT06581575","title":"A Phase 2, Randomized, Triple-Blinded, Active-Controlled Study to Assess the Safety and Immunogenicity of an Investigational Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects ≥ 50 Years of Age","has_exemption":false,"start_date":"2024-10-16","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Immorna Biotherapeutics, Inc.","sponsor_slug":"immorna-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06511778","publication_url":"https://clinicaltrials.gov/study/NCT06511778","title":"sTErnAl heMostasiS Trial (TEAMS Trial)","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"WakeMed Health and Hospitals","sponsor_slug":"wakemed-health-and-hospitals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668064","publication_url":"https://clinicaltrials.gov/study/NCT06668064","title":"A 2-year Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD","has_exemption":false,"start_date":"2024-10-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"EyePoint Pharmaceuticals, Inc.","sponsor_slug":"eyepoint-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06049680","publication_url":"https://clinicaltrials.gov/study/NCT06049680","title":"A Single-arm Open-label Safety Study of SMOFlipid to Evaluate the Risk of Developing Essential Fatty Acid Deficiency (EFAD) and/or Parenteral Nutrition-associated Cholestasis (PNAC) in Pediatric Patients 1 Month to 17 Years of Age and in Adult Patients, Who Are Anticipated to Need 8 Weeks or Longer of Parenteral Nutrition Treatment","has_exemption":false,"start_date":"2024-10-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Fresenius Kabi","sponsor_slug":"fresenius-kabi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05909059","publication_url":"https://clinicaltrials.gov/study/NCT05909059","title":"Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy in Patients With Moderate-Severe Renal Dysfunction","has_exemption":false,"start_date":"2024-11-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northside Hospital, Inc.","sponsor_slug":"northside-hospital-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06669754","publication_url":"https://clinicaltrials.gov/study/NCT06669754","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema","has_exemption":false,"start_date":"2024-12-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Pharvaris Netherlands B.V.","sponsor_slug":"pharvaris-netherlands-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655610","publication_url":"https://clinicaltrials.gov/study/NCT06655610","title":"External Trigeminal Nerve Stimulation Versus Sham Stimulation for Attention Deficit Hyperactivity Disorder in Children and Adolescents Aged 7-17 Years: Study Protocol for a Pilot and Feasibility Randomized Clinical Trial","has_exemption":false,"start_date":"2024-12-05","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Psychiatric Research Unit, Region Zealand, Denmark","sponsor_slug":"psychiatric-research-unit-region-zealand-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594705","publication_url":"https://clinicaltrials.gov/study/NCT06594705","title":"Transcatheter Aortic Valve Replacement Using the JenaValve TrilogyTM Heart Valve System for Clinically Significant Aortic Regurgitation in Patients With Left Ventricular Assist Devices (LVAD)","has_exemption":false,"start_date":"2024-12-09","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"JenaValve Technology, Inc.","sponsor_slug":"jenavalve-technology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06564818","publication_url":"https://clinicaltrials.gov/study/NCT06564818","title":"A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder","has_exemption":false,"start_date":"2024-12-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cybin IRL Limited","sponsor_slug":"cybin-irl-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06775379","publication_url":"https://clinicaltrials.gov/study/NCT06775379","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder","has_exemption":false,"start_date":"2024-12-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525896","publication_url":"https://clinicaltrials.gov/study/NCT06525896","title":"Research on Effectiveness of Non-surgical Spinal Decompression Therapy and Outcomes With Radiographic Evaluation","has_exemption":false,"start_date":"2025-01-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06691191","publication_url":"https://clinicaltrials.gov/study/NCT06691191","title":"Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors: Pharmadodynamic Comparison Between Prasugrel and Ticagrelor Monotherapy. The Switching Antiplatelet -7 (SWAP-7) Study","has_exemption":false,"start_date":"2025-01-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06848946","publication_url":"https://clinicaltrials.gov/study/NCT06848946","title":"Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06178289","publication_url":"https://clinicaltrials.gov/study/NCT06178289","title":"The Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Partial-thickness Wounds Caused by Moisture-associated Skin Damage Compared to Usual Wound Care Treatment in Hospitals: a Multi-centre RCT","has_exemption":false,"start_date":"2025-01-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University Ghent","sponsor_slug":"university-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06705075","publication_url":"https://clinicaltrials.gov/study/NCT06705075","title":"Evaluation of Uterine Fibroids by Contrast Enhanced Ultrasound (CEUS) and Subharmonic- Aided Pressure Estimation (SHAPE) Pre and Post-Uterine Artery Embolization (UAE)","has_exemption":false,"start_date":"2025-01-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809595","publication_url":"https://clinicaltrials.gov/study/NCT06809595","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama","has_exemption":false,"start_date":"2025-01-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Definium Therapeutics US, Inc.","sponsor_slug":"definium-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462482","publication_url":"https://clinicaltrials.gov/study/NCT06462482","title":"Peri-Operative Testosterone Administration in Primary Hip Arthroscopy","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"American Hip Institute","sponsor_slug":"american-hip-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727110","publication_url":"https://clinicaltrials.gov/study/NCT06727110","title":"Dentin Caries and Polymer-induced Liquid Precursor System (PILP): Adult Safety Study","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782386","publication_url":"https://clinicaltrials.gov/study/NCT06782386","title":"A Prospective Observational Study Evaluating the Effectiveness of Photographic and Thermal Monitoring in the Management of High-risk Diabetic Foot Patients","has_exemption":false,"start_date":"2025-02-05","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Bluedrop Medical Limited","sponsor_slug":"bluedrop-medical-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780332","publication_url":"https://clinicaltrials.gov/study/NCT06780332","title":"A Phase 4 Study to Evaluate the Impact of a Rapid Drug Desensitization (RDD) Protocol for Adults With Phenylketonuria and Experiencing Hypersensitivity Reactions to Palynziq","has_exemption":false,"start_date":"2025-02-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07203326","publication_url":"https://clinicaltrials.gov/study/NCT07203326","title":"Microsurfaced Acellular Dermal Matrix for Root Coverage Procedures","has_exemption":false,"start_date":"2025-02-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727565","publication_url":"https://clinicaltrials.gov/study/NCT06727565","title":"VELOCITY-HNSCC Substudy-01: A Phase 2 Study of Novel Combination Therapies in Participants With Previously Untreated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status","has_exemption":false,"start_date":"2025-02-18","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06681233","publication_url":"https://clinicaltrials.gov/study/NCT06681233","title":"A Feasibility Study of a Novel Cone-Beam CT Approach for Image Guided Radiotherapy in Cancer Patients","has_exemption":false,"start_date":"2025-02-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736392","publication_url":"https://clinicaltrials.gov/study/NCT06736392","title":"Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Ultrasound Guided Pericapsular Nerve Group Block for Postoperative Analgesia During Spinal Anesthesia in Hip Replacement Surgeries, a Randomized Controlled Study","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06587282","publication_url":"https://clinicaltrials.gov/study/NCT06587282","title":"Multicenter, Single Arm Prospective, Non-Randomized Study Designed to Evaluate the Safety and Effectiveness of the BLOOM™ Micro-Occluder System for the Treatment of Patent Ductus Arteriosus (PDA) in Pre-mature Infants (PREEMIE)","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Merit Medical Systems, Inc.","sponsor_slug":"merit-medical-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947760","publication_url":"https://clinicaltrials.gov/study/NCT05947760","title":"Magnesium as an Adjuvant Agent for Postoperative Pain Control Following Periacetabular Osteotomy","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822049","publication_url":"https://clinicaltrials.gov/study/NCT06822049","title":"Improving Efficiency, Quality, and Equity: Randomized Controlled Evaluations of Remote vs. In-Person Clinical Trial Methods; Remote vs. In-Person Study Evaluation (RISE) Trials","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06611397","publication_url":"https://clinicaltrials.gov/study/NCT06611397","title":"Double-Blinded Pilot Feasibility Study of the Discogen Device to Alleviate Discogenic Back/Radicular Leg Pain","has_exemption":false,"start_date":"2025-03-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915818","publication_url":"https://clinicaltrials.gov/study/NCT06915818","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Ileo-colic and Colo-colonic Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915337","publication_url":"https://clinicaltrials.gov/study/NCT06915337","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Gastric-Jejunal Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984835","publication_url":"https://clinicaltrials.gov/study/NCT06984835","title":"A Prospective, Multi-Center, Randomized, Controlled, Double-Blind, Split-Face Study of the Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AQTIS Medical B.V.","sponsor_slug":"aqtis-medical-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06693726","publication_url":"https://clinicaltrials.gov/study/NCT06693726","title":"ANGIOtensin II for Septic Shock in the Emergency Department: ANGIO-ED Study","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Brett A Faine","sponsor_slug":"brett-a-faine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06889701","publication_url":"https://clinicaltrials.gov/study/NCT06889701","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in Participants With Early or Acute Hematogenous PJI Requiring or Not Requiring DAIR After TKA, or Requiring Long-term Antibiotic Therapy","has_exemption":false,"start_date":"2025-04-03","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"TenNor Therapeutics Inc.","sponsor_slug":"tennor-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06235567","publication_url":"https://clinicaltrials.gov/study/NCT06235567","title":"Comparison of Intracanalicular Steroid-eluting Insert (Dextenza) to Topical Steroid Eye Drops for the Postoperative Management of Corneal Collagen Crosslinking","has_exemption":false,"start_date":"2025-04-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Maanasa Indaram, MD","sponsor_slug":"maanasa-indaram-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906341","publication_url":"https://clinicaltrials.gov/study/NCT06906341","title":"An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers (BELLA)","has_exemption":false,"start_date":"2025-04-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06909214","publication_url":"https://clinicaltrials.gov/study/NCT06909214","title":"A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2025-04-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810804","publication_url":"https://clinicaltrials.gov/study/NCT06810804","title":"A Phase IIa Study to Evaluate the Efficacy and Safety of NBQ72S in Breast Cancer Patients With Leptomeningeal Metastases, With or Without Brain Parenchymal Metastases","has_exemption":false,"start_date":"2025-04-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Nantong Bencao Quadriga Medical Technology Co. Ltd.","sponsor_slug":"nantong-bencao-quadriga-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447882","publication_url":"https://clinicaltrials.gov/study/NCT07447882","title":"Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task","has_exemption":false,"start_date":"2025-04-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935409","publication_url":"https://clinicaltrials.gov/study/NCT06935409","title":"A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of HS-20093 for Injection Versus Gemcitabine in Combination With Docetaxel in the Treatment of Osteosarcoma After Previous Second-line Treatment Failure (ARTEMIS-011)","has_exemption":false,"start_date":"2025-04-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Hansoh BioMedical R&D Company","sponsor_slug":"hansoh-biomedical-rd-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847191","publication_url":"https://clinicaltrials.gov/study/NCT06847191","title":"A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"BioVie Inc.","sponsor_slug":"biovie-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669352","publication_url":"https://clinicaltrials.gov/study/NCT05669352","title":"A Phase 1/2 Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases","has_exemption":false,"start_date":"2025-04-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06859164","publication_url":"https://clinicaltrials.gov/study/NCT06859164","title":"Genicular Artery Embolization for Reducing Pain in Symptomatic Knee Osteoarthritis: A Pilot Randomized Sham-Controlled Study","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942949","publication_url":"https://clinicaltrials.gov/study/NCT06942949","title":"Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Avvio Medical","sponsor_slug":"avvio-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05710315","publication_url":"https://clinicaltrials.gov/study/NCT05710315","title":"Single-center, Proof of Concept, Prospective Study Evaluating the Utility of RELiZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure","has_exemption":false,"start_date":"2025-05-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029009","publication_url":"https://clinicaltrials.gov/study/NCT07029009","title":"Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mansa","sponsor_slug":"mansa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133387","publication_url":"https://clinicaltrials.gov/study/NCT06133387","title":"PARADIGM Study: Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"EndoQuest Robotics, Inc.","sponsor_slug":"endoquest-robotics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903975","publication_url":"https://clinicaltrials.gov/study/NCT06903975","title":"The Effect of Injection of prabotulinumtoxinA-xvfs (Jeuveau) Into the Bilateral Sternocleidomastoid Muscles on Neck Circumference and Aesthetics","has_exemption":false,"start_date":"2025-05-14","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680244","publication_url":"https://clinicaltrials.gov/study/NCT07680244","title":"(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000","has_exemption":false,"start_date":"2025-05-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Carl Zeiss Meditec-Dublin CoCe","sponsor_slug":"carl-zeiss-meditec-dublin-coce","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011706","publication_url":"https://clinicaltrials.gov/study/NCT07011706","title":"A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ATI-045 in Patients With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-05-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Aclaris Therapeutics, Inc.","sponsor_slug":"aclaris-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06639464","publication_url":"https://clinicaltrials.gov/study/NCT06639464","title":"Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07173530","publication_url":"https://clinicaltrials.gov/study/NCT07173530","title":"Low Level Light Therapy & Skin Pigmentation","has_exemption":false,"start_date":"2025-06-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Houston","sponsor_slug":"university-of-houston","status":"ongoing","is_pact":false,"days_late":null}]}